Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study)
Author(s) -
Sergio SerranoVillar,
María Lagarde,
Jorge F. VázquezCastellanos,
Alejandro Vallejo,
José I Bernadino,
Nadia Madrid,
Mariano Matarranz,
Alberto Díaz-Santiago,
Carolina Gutiérrez,
Alfonso Cabello,
Judit Villar-García,
José Ramón Blanco,
Otilia Bisbal,
Talía Sainz,
Andrés Moyá,
Santiago Moreno,
María José Gosalbes,
Vicente Estrada
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy414
Subject(s) - medicine , placebo , clinical endpoint , adverse effect , randomized controlled trial , gastroenterology , immunology , clinical trial , cd8 , viral load , human immunodeficiency virus (hiv) , immune system , pathology , alternative medicine
While nutritional interventions with prebiotics and probiotics seem to exert immunological effects, their clinical implications in human immunodeficiency virus (HIV)-infected subjects initiating antiretroviral therapy (ART) at advanced HIV disease remain unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom